NCT01279915View on ClinicalTrials.gov

A Safety and Pharmacokinetics Study of ASP0456 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
HealthyPharmacokinetics of ASP0456
Interventions
DRUG

ASP0456

oral

DRUG

Placebo

oral

Trial Locations (1)

Unknown

Kantou

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY